Page 100 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation

Chapter 4
Supplemental Table 5. GRRAS checklist for reporting reliability and agreement studies.
Title and abstract
Introduction
Methods
Results
Discussion
Auxiliary material
1. Identify in title or abstract that interrater/intrarater reliability or agreement was investigated.
2. Name and describe the diagnostic or measurement device of interest explicitly.
3. Specify the subject population of interest.
4. Specify the rater population of interest (if applicable).
5. Describe what is already known about reliability and agreement and provide a rationale for the study (if applicable).
6. Explain how the sample size was chosen. State the determined number of raters, subjects/objects, and replicate observations.
7. Describe the sampling method.
8. Describe the measurement/rating process (e.g. time interval between repeated measurements, availability of clinical information, blinding).
9. State whether measurement/ratings were conducted independently.
10. Describe the statistical analysis.
11. State the actual number of raters and subjects/objects which were included and the number of replicate observations which were conducted.
12. Describe the sample characteristics of raters and subjects (e.g. training, experience).
13. Report estimates of reliability and agreement including measures of statistical uncertainty.
14. Discuss the practical relevance of results.
15. Provide detailed results if possible (e.g. online).
Reported on page number(s):
1,3 5,6
5 Methods 6 5
6
5,6 6
6
7 7-9
7,8 + methods 8,9
10-14, esp 13,14 Supplementals
“Reprinted from J Clin Epidemiol, 64 (1), Kottner J, Audigé L, Brorson S, et al. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed, Table 1, Page 98, Copyright 2011 with permission from Elsevier.”
98